Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

folate

folate is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 16
Pipeline programs 7
News articles 0
Drug details — folate
Class
—
Route
—
Patents
16
Programs
7
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

folate is an FDA-listed pharmaceutical active ingredient.

Key facts

INN folate

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. IMGN853-0424 Phase 2 · AbbVie Deutschland GmbH · Recurrent Ovarian Cancer with High Folate Receptor-Alpha Exp
  2. Natrunix with MTX placebo (+folate) Phase 2 · XBiotech Germany · Rheumatoid Arthritis
  3. [18F]Fluor-PEG-Folate Phase 2 · Disc Medicine · giant cell arteritis
  4. Folic Acid 5 MG Phase 1 · University of Hong · Acute Kidney Injury
  5. STRO-002-GM2 Phase 1 · SUTRO BIOPHARMA · Advanced Epithelial Ovarian Cancer (including Fallopian Tube
  6. [18F]fluoro-PEG-folate PET/CT scan Phase 1 · BRIGHT MINDS BIOSCIENCES · Epithelial Ovarian Cancer
  7. Arcofolin® 5-Methyltetrahydrofolate Unknown · United Therapeutics Europe · Pre-Eclampsia

Related patents

Browse patents

  1. WO 2026039306

    BÉTAÏNE ET FOLATE POUR FAVORISER LA MATURATION DU CERVEAU D'UN NOURRISSON

    Expires Wed Feb 14 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12427201

    Anti-folate receptor antibody conjugates, compositions comprising anti-folate receptor antibody conjugates, and methods of making and using anti-folate receptor antibody conjugates

    Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12071477

    Anti-folate receptor alpha antibody conjugated with hemiasterlins

    Expires Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. CA 3172190

    COMPOSITION COMPRENANT DU METHYLFOLATE

    Expires Wed Nov 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10870625

    Zwitterionic propargyl-linked antifolates useful for treating bacterial infections

    Expires Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10596270

    Anti-folate receptor antibody conjugates, compositions comprising anti-folate receptor antibody conjugates, and methods of making and using anti-folate receptor antibody conjugates

    Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10231974

    Pharmaceutical composition effective in preventing the adverse effects associated with the prolonged use of dihydrofolate reductase inhibitors

    Expires Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9914773

    Anti-human folate receptor beta antibodies and methods of use

    Expires Mon Mar 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9562070

    Induction of tumor immunity by variants of folate binding protein

    Expires Mon Feb 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9382213

    Heterocyclic and cyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase

    Expires Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8871206

    Anti-human folate receptor beta antibodies and methods of use

    Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8853228

    Heterocyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase

    Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8680319

    Method for producing antifolate agents having glutamic acid part in their structure

    Expires Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8507455

    Folate conjugates

    Expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8426432

    Inhibitors of dihydrofolate reductase with antibacterial antiprotozoal, antifungal and anticancer properties

    Expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7547759

    Induction of tumor immunity by variants of folate binding protein

    Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is folate?

folate is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.